At least 17 million people in Europe suffered long Covid in first 2 years of pandemic, WHO report says

At least 17 million people in Europe suffered long Covid in first 2 years of pandemic, WHO report says


New research suggests at least 17 million people across Europe and central Asia suffered from long Covid within the first two years of the pandemic.

Filadendron | E+ | Getty Images

At least 17 million people in Europe suffered from “long Covid” within the first two years of the coronavirus pandemic, according to a new study released Tuesday by the World Health Organization.

Around 10% to 20% of all Covid-19 cases reported in 2020 and 2021 across the region resulted in lingering effects lasting at least three months, with symptoms ranging from chronic fatigue to brain fog and breathlessness, the report found.

Women were also twice as likely as men to experience long Covid. Among serious cases resulting in hospitalization, one in three women were found to develop long-term symptoms.

The research, which was conducted by the Institute of Health Metrics and Evaluation at the University of Washington’s School of Medicine, pertains to the WHO’s Europe region, which is home to nearly 900 million people in 53 states across Europe and Central Asia.

‘Debilitating symptoms’

Long Covid refers to a range of mid- and long-term effects that can emerge following a Covid infection. Those can include fatigue, breathlessness and cognitive dysfunction, such as confusion and forgetfulness.

Some people’s mental health can also be impacted, either directly or indirectly.

While the majority of people fully recover from Covid, Dr. Hans Kluge, the WHO’s regional director for Europe, said the findings highlight the urgent need for more analysis and investment in monitoring the drawn out effects of the illness.

“Millions of people in our region, straddling Europe and central Asia, are suffering debilitating symptoms many months after their initial Covid-19 infection,” Kluge said.

Expedia CEO says travel is booming and business travelers are back

“They cannot continue to suffer in silence,” he continued. “Governments and health partners must collaborate to find solutions based on research and evidence.”

Cases of long Covid rose more than 300% in 2021 compared with 2020, in line with the drawn out nature of the illness, the study found.

Worldwide, 145 million people are estimated to have developed long Covid during 2020 and 2021, according to IHME data.

The director of IHME, Dr. Christopher Murray, said the findings should also raise awareness about the implications of long Covid for mental health and workplace wellbeing.

“Knowing how many people are affected and for how long is important for health systems and government agencies to develop rehabilitative and support services,” Murray said.



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More